Assessing the safety, impact and effectiveness of RTS,S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up

Assessing the safety, impact and effectiveness of RTS,S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up

Background: Following a 30-year development process, RTS,S/AS01E (GSK, Belgium) is the first malaria vaccine to reach Phase IV assessments. The World Health Organization-commissioned Malaria Vaccine Implementation Programme (MVIP) is coordinating the delivery of RTS,S/AS01E through routine national...

Full description

Bibliographic Details
Main Authors: Akité, E.J (Author), Ansah, P.O (Author), Asante, K.P (Author), Bahmanyar, E.R (Author), Baril, L. (Author), Boahen, O. (Author), Bozonnat, M.-C (Author), Haine, V. (Author), Kariuki, S. (Author), Lamy, M. (Author), Maleta, K. (Author), Mendoza, Y.G (Author), Mungwira, R. (Author), Ndeketa, L. (Author), Oduro, A. (Author), Ogutu, B. (Author), Olewe, F. (Author), Oneko, M. (Author), Orsini, M. (Author), Otieno, W. (Author), Pirçon, J.-Y (Author), Praet, N. (Author), Roman, F. (Author), Rosillon, D. (Author), Schuerman, L. (Author), Sing’oei, V. (Author), Terlouw, D.J (Author), Wéry, S. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Effectiveness
Impact
Malaria
Plasmodium falciparum
Protocol
RTS,S/AS01E
Safety
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items